1. Home
  2. HOWL vs GLE Comparison

HOWL vs GLE Comparison

Compare HOWL & GLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • GLE
  • Stock Information
  • Founded
  • HOWL 2017
  • GLE 2018
  • Country
  • HOWL United States
  • GLE Hong Kong
  • Employees
  • HOWL N/A
  • GLE N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • GLE
  • Sector
  • HOWL Health Care
  • GLE
  • Exchange
  • HOWL Nasdaq
  • GLE NYSE
  • Market Cap
  • HOWL 87.4M
  • GLE 28.7M
  • IPO Year
  • HOWL 2021
  • GLE 2024
  • Fundamental
  • Price
  • HOWL $1.49
  • GLE $1.30
  • Analyst Decision
  • HOWL Strong Buy
  • GLE
  • Analyst Count
  • HOWL 2
  • GLE 0
  • Target Price
  • HOWL $9.50
  • GLE N/A
  • AVG Volume (30 Days)
  • HOWL 260.9K
  • GLE 127.9K
  • Earning Date
  • HOWL 03-06-2025
  • GLE 11-01-2024
  • Dividend Yield
  • HOWL N/A
  • GLE N/A
  • EPS Growth
  • HOWL N/A
  • GLE N/A
  • EPS
  • HOWL N/A
  • GLE 0.02
  • Revenue
  • HOWL $3,386,000.00
  • GLE $6,333,093.00
  • Revenue This Year
  • HOWL N/A
  • GLE N/A
  • Revenue Next Year
  • HOWL $34.17
  • GLE N/A
  • P/E Ratio
  • HOWL N/A
  • GLE $62.57
  • Revenue Growth
  • HOWL N/A
  • GLE 10.67
  • 52 Week Low
  • HOWL $1.26
  • GLE $1.20
  • 52 Week High
  • HOWL $8.19
  • GLE $5.44
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 54.09
  • GLE N/A
  • Support Level
  • HOWL $1.28
  • GLE N/A
  • Resistance Level
  • HOWL $1.60
  • GLE N/A
  • Average True Range (ATR)
  • HOWL 0.10
  • GLE 0.00
  • MACD
  • HOWL 0.03
  • GLE 0.00
  • Stochastic Oscillator
  • HOWL 67.65
  • GLE 0.00

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About GLE GLOBAL ENGINE GROUP HOLDING LIMITED

Global Engine Group Holding Ltd offers integrated solutions by using ICT solutions to drive business outcomes and innovation. Its service offerings comprise services to telecom operators, including the one-stop shop purchase from telecom license application service to turnkey network setup as well as service outsourcing; business planning, development, technical and operations consulting programs structured to target the cloud computing and data center providers; system design, planning, development and operation services to technology companies; cloud platform deployment, IT system design and configuration services, maintenance services, data center colocation service and cloud service.

Share on Social Networks: